This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1996 Mar;22(2):79-87.

doi: 10.1016/1040-8428(95)00188-3.

Status of new anthrapyrazole and pyrazoloacridine derivatives

S L Berg¹

Affiliations

PMID: 8679102
DOI: 10.1016/1040-8428(95)00188-3

Review

Status of new anthrapyrazole and pyrazoloacridine derivatives

S L Berg. Crit Rev Oncol Hematol. 1996 Mar.

. 1996 Mar;22(2):79-87.

doi: 10.1016/1040-8428(95)00188-3.

Author

S L Berg¹

Affiliation

¹ Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

PMID: 8679102
DOI: 10.1016/1040-8428(95)00188-3

No abstract available

PubMed Disclaimer

Similar articles

Clinical trials referral resource. Clinical trials with pyrazoloacridine.
Murgo AJ, Cannon D, Christian MC, Cheson B, Nelson AP. Murgo AJ, et al. Oncology (Williston Park). 1997 Jul;11(7):991-4. Oncology (Williston Park). 1997. PMID: 9251119 No abstract available.
Current status of pyrazoloacridine as an anticancer agent.
Adjei AA. Adjei AA. Invest New Drugs. 1999;17(1):43-8. doi: 10.1023/a:1006242321596. Invest New Drugs. 1999. PMID: 10555121 Review.
Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors.
Vuky J, McCaffrey J, Ginsberg M, Mariani T, Bajorin DF, Bosl GJ, Motzer RJ. Vuky J, et al. Invest New Drugs. 2000 Aug;18(3):265-7. doi: 10.1023/a:1006434008357. Invest New Drugs. 2000. PMID: 10958596 Clinical Trial.
Anthracycline war: no victor yet.
Young P. Young P. J Natl Cancer Inst. 2009 Sep 2;101(17):1171-3. doi: 10.1093/jnci/djp303. Epub 2009 Aug 25. J Natl Cancer Inst. 2009. PMID: 19706625 No abstract available.
Anthracyclines.
Myers CE. Myers CE. Cancer Chemother Biol Response Modif. 1992;13:45-52. Cancer Chemother Biol Response Modif. 1992. PMID: 1389917 Review. No abstract available.

See all similar articles

Cited by

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.
Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.
A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma.
Berg WJ, McCaffrey J, Schwartz LH, Mariani T, Mazumdar M, Motzer RJ. Berg WJ, et al. Invest New Drugs. 1998-1999;16(4):337-40. doi: 10.1023/a:1006143008040. Invest New Drugs. 1998. PMID: 10426668

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science